Publications
5891 Results
- Journal / Conference
- Blood 120(21):abst.543; American Society of Hematology Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9704
MYC protein expression, but not high grade morphology, is associated with poor outcome in non-Burkitt diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study
- Journal / Conference
- Blood 120(21):abst. 3535; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Differences in outcomes in males and females with diffuse large B-cell lymphoma and follicular lymphoma treated with rituximab (ECOG E4494, CALGB 9793, SWOG E4494, E1496)
- Journal / Conference
- Cancer Epidemiology Biomarkers and Prevention 21(10):1823-1832
- Year
- 2012
- Research Committee(s)
- Cancer Control
- PMID
- PMID22879203
- PMC
- PMC3467348
- Study Number(s)
- SWOG-9217
Associations of serum sex steroid hormones and 5a-androstane-3a,17B-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride
- Journal / Conference
- American Journal of Epidemiology 175(2):
- Year
- 2012
- Research Committee(s)
- Cancer Control
- PMID
- PMID22759721
- PMC
- PMC3493197
- Study Number(s)
- SWOG-9217
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial [PMID22759721; PMC3493197]
- Journal / Conference
- International Journal of Radiation Oncology, Biology & Physics 84(3):e291-297
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID22682806
- PMC
- n/a
- Study Number(s)
- R9704
Five year results of US Intergroup/RTOG 9704 with postoperative CA 19-9 < 90 U/mL and comparison to the CONKO-001 Trial
- Journal / Conference
- Current Oncology Reports 14(6):502-508;
- Year
- 2012
- Research Committee(s)
- Outcomes and Comparative Effectiveness
- PMID
- PMID22907283
- PMC
- PMC3490046
The automatic clinical trial: leverging the electronic medical record in multisite cancer clinical trials
- Journal / Conference
- Clinical Cancer Research 18(14):3731-3736
- Year
- 2012
- Research Committee(s)
- Myeloma
- PMID
- PMID22675175
- PMC
- PMC3744099
Cure model as a useful statistical tool for analyzing survival
- Journal / Conference
- Breast Cancer Research and Treatment 134(2):683-692
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID22547108
- PMC
- PMC3552372
- Study Number(s)
- E2197
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197
- Journal / Conference
- Blood 120(10):2098-2108
- Year
- 2012
- Research Committee(s)
- Leukemia
- PMID
- PMID22734072
- PMC
- PMC3437597
- Study Number(s)
- C9710
Treatment influenced associations of PML-RARa mutations, FLT3 mutations and additional chromosome abnormalities in relapse acute promyelocytic leukemia [PMID22734072]
- Journal / Conference
- Handbook of Statistics in Clinical Oncology, J Crowley & A Hoering, Editors, 3rd edition, CRC Press, Ch. 19, P. 293-304
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- n/a
- PMC
- n/a
- Study Number(s)
- S1007